Sheng-Jie Guo (Shengjie Guo)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Prognostic Factors

Renal Cell Carcinoma

Top Venues

Cancer medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Nan Ma, Yi-Xiang Gan, Yin-Yao Chao, Zhen-Hua Liu, Xian-Da Chen, Kai Yao, Hui Han, Sheng-Jie Guo
Trajectories of squamous cell carcinoma antigen and outcomes of patients with advanced penile cancer after chemotherapy based on paclitaxel, ifosfamid, and cisplatin regimen. Cancer medicine 13 (12) (2024)
Nan Ma, Yi-Xiang Gan, Yin-Yao Chao, Zhen-Hua Liu, Xian-Da Chen, Kai Yao, Hui Han, Sheng-Jie Guo
Trajectories of squamous cell carcinoma antigen and outcomes of patients with advanced penile cancer after chemotherapy based on paclitaxel, ifosfamid, and cisplatin regimen. Cancer medicine 13 (12) (2024)
Lichao Wei, Zaishang Li, Sheng-Jie Guo, Huali Ma, Yanxia Shi, Xin An, Kangbo Huang, Longbin Xiong, Ting Xue, Zhiling Zhang, Kai Yao, Junhang Luo, Hui Han
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy. Cancer (2023)
Lichao Wei, Zaishang Li, Sheng-Jie Guo, Huali Ma, Yanxia Shi, Xin An, Kangbo Huang, Longbin Xiong, Ting Xue, Zhiling Zhang, Kai Yao, Junhang Luo, Hui Han
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy. Cancer 130 (9) (2023)
Lichao Wei, Zaishang Li, Sheng-Jie Guo, Huali Ma, Yanxia Shi, Xin An, Kangbo Huang, Longbin Xiong, Ting Xue, Zhiling Zhang, Kai Yao, Junhang Luo, Hui Han
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy. Cancer 130 (9) (2023)
Pei Dong, Xinyue Zhang, Yu-Lu Peng, Yijun Zhang, Ruiqi Liu, Yilin Li, Qiwen Pan, Wen-Su Wei, Sheng-Jie Guo, Zhiling Zhang, Hui Han, Fang-Jian Zhou, Yang Liu, Liru He
Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Fangjian Zhou, Lijuan Jiang, Zhiling Zhang, Minhua Deng, Wensu Wei, Huancheng Tang, Sheng-Jie Guo, Yunlin Ye, Kai Yao, Zhuo-Wei Liu, Fangjian Zhou
Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system. Cancer medicine (2021)
Sheng-Jie Guo, Kai Yao, Xiaobo He, Shulin Wu, Yun-Lin Ye, Junxing Chen, Chin-Lee Wu
Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database. Cancer medicine 8 (12) (2019)